Dashboard
Manage Tickers

RLMD RELMADA THERAPEUTICS, INC.

Nasdaq relmada.com


$ 4.26 $ -0.01 (-0.23 %)    

Thursday, 20-Nov-2025 14:28:38 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 591.27 $ -20.40 (-3.34 %)
DIA $ 460.39 $ -6.29 (-1.35 %)
SPY $ 657.48 $ -15.42 (-2.29 %)
TLT $ 89.21 $ 0.22 (0.24 %)
GLD $ 375.45 $ 0.31 (0.08 %)
$ 4.18
$ 4.37
$ 4.22 x 100
$ 4.26 x 100
$ 4.14 - $ 4.54
$ 0.24 - $ 5.12
2,464,062
na
138.74M
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-19-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-25-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-10-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-24-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-12-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 11-13-2019 09-30-2019 10-Q
25 09-24-2019 06-30-2019 10-K
26 05-15-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-Q
28 11-13-2018 09-30-2018 10-Q
29 09-28-2018 06-30-2018 10-K
30 05-14-2018 03-31-2018 10-Q
31 02-12-2018 12-31-2017 10-Q
32 11-14-2017 09-30-2017 10-Q
33 09-28-2017 06-30-2017 10-K
34 05-15-2017 03-31-2017 10-Q
35 02-10-2017 12-31-2016 10-Q
36 11-10-2016 09-30-2016 10-Q
37 09-09-2016 06-30-2016 10-K
38 05-09-2016 03-31-2016 10-Q
39 02-05-2016 12-31-2015 10-Q
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mizuho-upgrades-relmada-therapeutics-to-outperform-raises-price-target-to-10
Mizuho Upgrades Relmada Therapeutics to Ou...
11/19/2025 14:36:38

Mizuho analyst Uy Ear upgrades Relmada Therapeutics (NASDAQ:RLMD) from Neutral to Outperform and raises the price target fro...

relmada-therapeutics-q3-eps-030-misses-004-estimate
Relmada Therapeutics Q3 EPS $(0.30) Misses...
11/13/2025 21:03:08

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate o...

earnings-scheduled-for-november-13-2025
Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

a-glimpse-of-relmada-therapeuticss-earnings-potential
A Glimpse of Relmada Therapeutics's Earnin...
11/12/2025 18:02:45

relmada-prices-100m-equity-offering-including-4014m-common-shares--at-220-each-and-532m-pre-funded-warrants-at-2199-each
Relmada Prices $100M Equity Offering Inclu...
11/04/2025 12:16:23

relmada-receives-fda-support-for-two-registrational-study-paths-for-ndv-01-in-bladder-cancer-reports-92-overall-response-at-9-months-with-strong-safety-profile
Relmada Receives FDA Support For Two Regis...
11/04/2025 12:08:53

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 12:05:48

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/06/2025 17:07:04

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/03/2025 17:06:08

relmada-regains-compliance-with-nasdaq-1-minimum-bid-price-requirement
Relmada Regains Compliance With Nasdaq $1 ...
09/16/2025 13:05:17

relmada-ceo-sergio-traversa-reports-91-complete-response-rate-in-phase-2-ndv-01-study-for-non-muscle-invasive-bladder-cancer
Relmada CEO Sergio Traversa Reports 91% Co...
09/10/2025 11:18:38

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

relmada-therapeutics-cmo-raj-s-pruthi-purchases-55000-shares-in-open-market-on-august-29-2025
Relmada Therapeutics CMO Raj S. Pruthi Pur...
09/02/2025 15:40:12

On August 29, 2025, Raj S. Pruthi, MD, Chief Medical Officer-Urology of Relmada Therapeutics, Inc. (the "Company"), pur...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/29/2025 17:05:57

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/29/2025 12:07:49

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

relmada-therapeutics-q2-eps-030-misses-002-estimate
Relmada Therapeutics Q2 EPS $(0.30) Misses...
08/07/2025 20:07:15

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

why-medpace-shares-are-trading-higher-by-45-here-are-20-stocks-moving-premarket
Why Medpace Shares Are Trading Higher By 4...
07/22/2025 09:39:38

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION